Silver Nanoparticles for Drug Delivery

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience across various countries. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, and “SERB-Ramanujan Fellowship Award”. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

• PrefacePart A: Synthesis and characterization of silver nanoparticlesfor drug delivery1. History, introduction, and physicochemical properties of silver nanoparticles2. Synthesis methods and characterization parameters of silver nanoparticlesPart B: Application of silver nanoparticles in drug delivery3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery5. Silver nanoparticles for cancer diagnosis and treatment of cancer6. Silver nanoparticles to enhance photodynamic action of photosensitizers7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm8. Silver nanoparticles in wound therapy and tissue regeneration9. Silver nanoparticles for drug delivery in inflammatory bowel disease10. Silver nanoparticles for the management of neurological diseases11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements12. Silver nanoparticles in dentistry13. Silver nanoparticles and their role in the treatment of endodontic infections14. Silver nanoparticles for treatment of COVID-19 and other viral diseasesPart C: Recent advances and regulatory aspects of silver nanoparticles15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles16. Silver nanoparticleinduced ecotoxicity17. Clinical translation of silver nanoparticles into the market18. Conclusion and future prospective of silver nanoparticles